检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张铸[1] 叶萍[1] 陈叶芳[1] 陈阳[1] 张寄南[2]
机构地区:[1]江苏省靖江市人民医院心内科,214500 [2]江苏省人民医院心内科
出 处:《中国心血管病研究》2003年第3期175-177,共3页Chinese Journal of Cardiovascular Research
摘 要:目的通过比较急性心肌梗死(AMI)患者胸痛发作后各时间段血清肌钙蛋白I(cTnI)浓度与住院期间存活和死亡关系,探讨cTnI浓度在急性心肌梗死中的临床价值。方法对172例AMI患者在不同时间段进行血清cTnI浓度测定,比较住院期间存活组与死亡组血清cTnI浓度的变化,以及冠状动脉(冠脉)再灌注对其的影响。结果 AMI患者住院期间死亡患者的血清cTnI浓度明显高于存活患者;住院期间存活患者中胸病发作后18h内,再通者明显高于未通者;住院期间死亡患者中冠脉再通与未通者血清cTnI浓度差异无显著性。结论 血清cTnI浓度与ANI患者的预后有关,死亡患者在胸痛发作后各时间段的血清cTnI浓度均明显升高;存活患者冠脉再通峰浓度增高,峰值提前;死亡患者再灌注与否对血清cTnI浓度无明显影响。Objective To assess the clinical value of serum cardiac troponin I on patients with acute myocardial infarction(AMI) and compared the concentration of serum cardiac troponin I (cTn I ) with fatality rates during hospitalization and reperfusion. Methods Blood samples of 172 cases with AMI were collected at specific time points. Concentration of serum cardiac troponin I were compared among following groups: survival, dead, reperfusion, non - reperfusion. Results The serum cTn I concentrations of dead during hospitalization were significantly higher than that of survival at all time points after chest pain onset. In the survival group, The serum cTn I concentrations of patients with reperfusion were significantly higher than that with non- reperfusion during the first 18 hours after onset of chest pain. In the dead group, there was no significantly difference between the serum cTn I concentration of reperfusion and non- reperfusion patients. Conclusion Serum cTn I concentration was associated with the prognosis of AMI patients during hospitalization. The serum cTn I concentrations were significantly higher than that in dead. Peak serum cTn I concentrations of reperfusion survival were higher and be put forward.
关 键 词:急性心肌梗死 住院期 血清肌钙蛋白I AMI CTNI
分 类 号:R542.22[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.40